These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague. Leary SE; Eley SM; Williamson ED; Titball RW Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838 [No Abstract] [Full Text] [Related]
44. An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague. Yamanaka H; Hoyt T; Bowen R; Yang X; Crist K; Golden S; Maddaloni M; Pascual DW Vaccine; 2009 Jan; 27(1):80-7. PubMed ID: 18955097 [TBL] [Abstract][Full Text] [Related]
45. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Anderson GW; Heath DG; Bolt CR; Welkos SL; Friedlander AM Am J Trop Med Hyg; 1998 Jun; 58(6):793-9. PubMed ID: 9660466 [TBL] [Abstract][Full Text] [Related]
46. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model. Shreewastav RK; Ali R; Uppada JB; Rao DN Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976 [TBL] [Abstract][Full Text] [Related]
48. [Experimental protective of fraction I of the plague microbe]. Pautov VN; Chicherin IuV; Evstigneev VI; Byvalov AA; Kedrov OA Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):37-42. PubMed ID: 116458 [TBL] [Abstract][Full Text] [Related]
49. Antibodies and cytokines independently protect against pneumonic plague. Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869 [TBL] [Abstract][Full Text] [Related]
50. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V). Fellows P; Adamovicz J; Hartings J; Sherwood R; Mega W; Brasel T; Barr E; Holland L; Lin W; Rom A; Blackwelder W; Price J; Morris S; Snow D; Hart MK Vaccine; 2010 Nov; 28(49):7748-56. PubMed ID: 20920572 [TBL] [Abstract][Full Text] [Related]
51. [The activity of NK and K cells in mice vaccinated against plague]. Solokhin EV; Pchelintsev SIu; Iurov SV; Uraeva VI; Afanas'ev SS; Vorob'ev AA Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):42-5. PubMed ID: 7992534 [TBL] [Abstract][Full Text] [Related]
52. [Construction of variants of Yersinia pestis EV76 (RIEG line) vaccine strain differing in antibiotic resistance spectra with stage-by-stage transduction of R-transposons]. Cherniavskaia AS; Morozova IV; Lebedeva SA; Zarenkov MI Antibiot Khimioter; 2005; 50(7):13-7. PubMed ID: 16768208 [TBL] [Abstract][Full Text] [Related]
53. Plague vaccines and the molecular basis of immunity against Yersinia pestis. Quenee LE; Schneewind O Hum Vaccin; 2009 Dec; 5(12):817-23. PubMed ID: 19786842 [TBL] [Abstract][Full Text] [Related]
54. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals]. Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966 [No Abstract] [Full Text] [Related]
55. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Garmory HS; Griffin KF; Brown KA; Titball RW Vaccine; 2003 Jun; 21(21-22):3051-7. PubMed ID: 12798649 [TBL] [Abstract][Full Text] [Related]
56. One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study. Hu J; Jiao L; Hu Y; Chu K; Li J; Zhu F; Li T; Wu Z; Wei D; Meng F; Wang B Hum Vaccin Immunother; 2018; 14(11):2701-2705. PubMed ID: 29927704 [TBL] [Abstract][Full Text] [Related]
57. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice. Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022 [TBL] [Abstract][Full Text] [Related]